ArticleFrontiers of medicine2024

First evidence of olaparib maintenance therapy in patients with newly diagnosed homologous recombination deficient positive/BRCA wild-type ovarian cancer: real-world multicenter study.

Jing Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.